Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 15/20 | 0.46 |
| ▸ | CTSS | P25774 | 7/20 | 0.46 |
| ▸ | CTSL | P07711 | 3/20 | 0.46 |
| ▸ | CTSB | P07858 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6786634 | 0.83 | CTSK (0.53) | CTSKCTSSCTSLCTSBCA1 | |
| SCHEMBL16564868 | 0.83 | CTSK (0.53) | CTSKCTSSCTSLCTSBCA1 | |
| SCHEMBL7433177 | 0.83 | CTSK (0.53) | CTSKCTSSCTSLCTSBCA1 | |
| SCHEMBL13263256 | 0.79 | CTSK (0.50) | CTSKCTSSCTSLCTSBCA1 | |
| SCHEMBL24981559 | 0.77 | CTSK (0.46) | CTSKCTSSCTSLCTSBCA1 | |
| SCHEMBL2900790 | 0.77 | CTSK (0.51) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL12635213 | 0.77 | CTSK (0.51) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL9511453 | 0.77 | CTSK (0.51) | CTSKCA1CA2CA7CYP2D6 | |
| SCHEMBL12635207 | 0.77 | CTSK (0.51) | CTSKCTSSCA1CA2CA7 | |
| SCHEMBL6289798 | 0.77 | CTSK (0.51) | CTSKCA1CA2CA7CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10815238-B2 | Antimicrobial compounds and methods of making and using the same | BioVersys AG (CH) | 2020-10-27 | — | — | US | disclosed |
| US-20190284190-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | BioVersys AG (CH) | 2019-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284190-A1 | ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | MPO, LPO, CAT | CTSK 122/4885CTSS 103/4885CTSL 37/4885 |
| US-10815238-B2 | Antimicrobial compounds and methods of making and using the same | MPO, LPO, CAT | CTSK 122/4885CTSS 103/4885CTSL 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.